Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 54 entries
View as:

A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06376136 Org: User:
Start: 05/08/24 End: 12/09/26 Due: 12/09/27

A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Phase: N/A Priority: Normal
NCT ID: NCT04146285 Org: User:
Start: 09/01/20 End: 06/01/23 Due: 06/01/24

A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients

Phase: N/A Priority: Normal
NCT ID: NCT04432766 Org: User:
Start: 10/20/20 End: 08/18/21 Due: 08/18/22

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China

Phase: N/A Priority: Normal
NCT ID: NCT05105971 Org: User:
Start: 12/23/21 End: 11/14/24 Due: 11/14/25

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06545617 Org: User:
Start: 01/31/25 End: 01/31/28 Due: 01/31/29

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy with BAT1308 in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05155722 Org: User:
Start: 09/17/20 End: 12/31/25 Due: 12/31/26

A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®

Phase: N/A Priority: Normal
NCT ID: NCT05332730 Org: User:
Start: 08/01/22 End: 07/10/23 Due: 07/10/24

A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection

Phase: N/A Priority: Normal
NCT ID: NCT05865574 Org: User:
Start: 06/30/23 End: 01/31/24 Due: 01/31/25

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05879627 Org: User:
Start: 01/17/23 End: 07/01/26 Due: 07/01/27

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection

Phase: N/A Priority: Normal
NCT ID: NCT05378737 Org: User:
Start: 07/06/22 End: 12/31/25 Due: 12/31/26

Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03030430 Org: User:
Start: 03/15/16 End: 06/28/17 Due: 06/28/18

A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients

Phase: N/A Priority: Normal
NCT ID: NCT04152148 Org: User:
Start: 09/04/18 End: 01/13/21 Due: 01/13/22

Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients

Phase: N/A Priority: Normal
NCT ID: NCT06139536 Org: User:
Start: 03/06/24 End: 02/28/26 Due: 02/28/27

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05148325 Org: User:
Start: 09/02/21 End: 12/31/24 Due: 12/31/25

A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients

Phase: N/A Priority: Normal
NCT ID: NCT04189211 Org: User:
Start: 03/07/17 End: 12/31/20 Due: 12/31/21

Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04371185 Org: User:
Start: 08/08/20 End: 04/19/21 Due: 04/19/22

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients

Phase: N/A Priority: Normal
NCT ID: NCT05109650 Org: User:
Start: 11/15/21 End: 03/23/23 Due: 03/23/24

A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira

Phase: N/A Priority: Normal
NCT ID: NCT04135508 Org: User:
Start: 12/13/16 End: 05/31/18 Due: 05/31/19

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China

Phase: N/A Priority: Normal
NCT ID: NCT05120375 Org: User:
Start: 02/17/22 End: 04/07/23 Due: 04/07/24

Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT03830203 Org: User:
Start: 12/19/18 End: 01/05/21 Due: 01/05/22

Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04152759 Org: User:
Start: 09/09/19 End: 12/31/20 Due: 12/31/21

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT05439629 Org: User:
Start: 07/28/22 End: 06/30/25 Due: 06/30/26

Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009

Phase: N/A Priority: Normal
NCT ID: NCT05405621 Org: User:
Start: 08/02/22 End: 12/31/24 Due: 12/31/25

Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05518695 Org: User:
Start: 06/09/22 End: 11/07/22 Due: 11/07/23

Evaluate the Safety, Tolerability of BAT6026

Phase: N/A Priority: Normal
NCT ID: NCT06094179 Org: User:
Start: 11/09/23 End: 10/15/25 Due: 10/15/26